Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24-Reference-Cited by-同舟云学术

Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24

Published:2015-11 Issue:6 Volume:16 Page:e189-e201
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Bar Jair^ORCID,Ding Keyue,Zhao Huijun,Han Lei,Laurie Scott A.,Seymour Lesley^ORCID,Addison Christina L.,Shepherd Frances A.,Goss Glenwood D.,Dimitroulakos Jim,Bradbury Penelope A.

Funder

Ottawa Regional Cancer Centre

Canadian Cancer Society Research Institute

Cancer Care Ontario Research Chair

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. The biology of VEGF and its receptors;Ferrara;Nat Med,2003

2. Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non–small-cell lung cancer: NCIC clinical trials group BR24 study;Goss;J Clin Oncol,2010

3. A randomized double-blind trial of carboplatin plus paclitaxel (CP) with daily oral cediranib (CED), an inhibitor of vascular endothelial growth factor receptors, or placebo (PLA) in patients (pts) with previously untreated advanced non-small cell lung cancer (NSCLC): NCIC Clinical Trials Group study BR29.

4. Ledermann JA. Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: results of the ICON6 trial (abstract). 2013.

5. A phase I study of cediranib (NSC #732208) in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma (SWOG S0905);Tsao;ASCO Annual Meeting Proceedings,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK;Journal of Cellular and Molecular Medicine;2023-03-23

2. Effects of aldosterone on the human placenta: Insights from placental perfusion studies;Placenta;2022-06

3. Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches;WIREs Nanomedicine and Nanobiotechnology;2021-09-19

4. Investigating the Role of Mineralocorticoid Receptor Signaling in Cancer Biology in the Genomic Era;Aldosterone-Mineralocorticoid Receptor - Cell Biology to Translational Medicine;2019-09-25

5. The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention;Oncogene;2018-11-26